GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,339,000 | +31.8% | 116,845 | -6.0% | 0.05% | +4.2% |
| Q1 2020 | $10,881,000 | -13.7% | 124,255 | +3.1% | 0.05% | +14.3% |
| Q4 2019 | $12,602,000 | -72.9% | 120,524 | -70.2% | 0.04% | -73.6% |
| Q3 2019 | $46,567,000 | -54.0% | 404,829 | -31.1% | 0.16% | -51.7% |
| Q2 2019 | $101,295,000 | +3.8% | 587,590 | +1.5% | 0.33% | +1.2% |
| Q1 2019 | $97,574,000 | +87.9% | 578,832 | +8.5% | 0.32% | +71.1% |
| Q4 2018 | $51,940,000 | -52.5% | 533,323 | -15.8% | 0.19% | -37.3% |
| Q3 2018 | $109,428,000 | +1.7% | 633,484 | -17.9% | 0.30% | -3.8% |
| Q2 2018 | $107,614,000 | +464.0% | 771,206 | +436.5% | 0.32% | +443.1% |
| Q3 2016 | $19,081,000 | +89.4% | 143,758 | +53.1% | 0.06% | +427.3% |
| Q2 2014 | $10,076,000 | +296.2% | 93,918 | +119.3% | 0.01% | +83.3% |
| Q1 2014 | $2,543,000 | – | 42,828 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |